Feedback / Questions
TTX-080 - Tizona Therap
https://www.globenewswire.com/news-release/2025/11/07/3183672/0/en/Tizona-Therapeutics-Presents-Clinical-Translational-Evidence-of-Dual-Innate-and-Adaptive-Immune-Activation-with-TTX-080-a-First-in-Class-HLA-G-Antagonist-in-Patients-with-Advanced-.html
Nov 7, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next